FBIO - התחייבויות לטווח ארוך של החברה Fortress Biotech Inc

Fortress Biotech, Inc. (FBIO) is implementing robotic laboratories and AI back-office services, while the asset's market value, as clearly illustrated on this chart, stands at 0.05. Fortress Biotech, Inc. (FBIO) is valued as a reliable incubator that monetizes oncology assets through licensing. As part of its ESG strategy, the firm invests in ethical research with minimal environmental impact, prioritizing eco-friendly developments.

Royalties from subsidiaries and drug sales provide operational stability for Fortress Biotech, Inc. (FBIO), which is reflected in the stability of the organization's long-term financial debt. This metric captures the total volume of credit obligations with maturities exceeding one year, allowing for an assessment of the debt load and the risk of profit shortfall due to a lack of financial leverage, while the holding's current risks are already priced in.